Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Market Update Willdan Group Soars Grifols Integration Update Amylyx Pharmaceuticals Trials Disappoint

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Financing and finances
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Exciting Updates for March 8th:

Willdan Group (WLDN): Shares of Willdan Group surged by 21% today after revealing impressive Q4 financial results and providing guidance for FY24 that exceeded expectations. The company also announced a lucrative contract worth $30-50 million spanning three years.

Grifols (GRFS): Grifols clarified that the integration discussed in the 2023 financial statements has no impact on the income statement or key metrics.

Amylyx Pharmaceuticals (AMLYX): Unfortunately, Amylyx Pharmaceuticals shared disappointing news that the PHOENIX Phase 3 trial for AMX0035 in treating Amyotrophic Lateral Sclerosis did not meet its primary endpoint. As a result, their shares plummeted by 81%.

WLDN Stock Performance on March 8, 2024: Pre-Market Surge Indicates Positive News Ahead

On March 8, 2024, the stock performance of WLDN, also known as Willdan Group, Inc., showed some interesting movements. According to data from CNN Money, WLDN is currently trading in the middle of its 52-week range and near its 200-day simple moving average.

The price of WLDN shares experienced a slight decrease of $0.06 since the market last closed, representing a 0.30% drop. The stock closed at $19.85 on the previous trading day. However, in pre-market trading, the stock has since risen by $4.14, indicating a significant increase in value.

This jump in pre-market trading suggests that there may be some positive news or developments surrounding WLDN that are driving investor interest and causing the stock price to rise. Investors will be keeping a close eye on how the stock performs throughout the trading day to see if this momentum continues or if there are any fluctuations.

Willdan Group, Inc. (WLDN) Stock Performance Analysis: Strong Growth in Net Income and EPS

On March 8, 2024, the stock performance of Willdan Group, Inc. (WLDN) showed promising results based on the financial data provided by CNN Money. The company reported a total revenue of $510.10 million for the past year, which represents an 18.87% increase compared to the previous year. However, the total revenue remained flat at $155.68 million for the last quarter.

In terms of net income, Willdan Group, Inc. reported a net income of $10.93 million for the past year, marking a significant increase of 229.33% compared to the previous year. Similar to the total revenue, the net income held flat at $8.03 million for the last quarter.

The earnings per share (EPS) for Willdan Group, Inc. also showed positive growth. The company reported an EPS of $0.80 for the past year, which represents a 223.23% increase compared to the previous year. Additionally, the EPS increased by 407.88% since the last quarter, reaching $0.58.

Overall, the financial performance of Willdan Group, Inc. on March 8, 2024, indicates strong growth in net income and EPS. Investors may find these results encouraging and may consider the company as a potential investment opportunity. It is important to conduct further research and analysis before making any investment decisions based on this information.

Tags: WLDN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Analysts Upbeat on Regenxbios Future Prospects

Finance_Business (2)

Financial Expert Downgrades Runway Growth Finance Corp from Overweight to Neutral

Biopharmaceutical Stock Market Today (1)

FDA Requests Further Information on Donanemab Delays Decision Timeline

Recommended

CRWD stock news

Tower Research Capital LLC TRC Demonstrates Unwavering Confidence in CrowdStrike Holdings as Cybersecurity Leader

2 years ago
Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

Beacon Announces Interim Chief Financial Officer

2 years ago

Alaska Airlines Boeing 737 Investigation Missing Bolts and Safety Measures

2 years ago

Impressive Financial Performance for Kiniksa Pharmaceuticals

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Trending

Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

by Rodolfo Hanigan
February 7, 2026
0

Universal Insurance Holdings has reaffirmed its commitment to shareholder returns, declaring its regular quarterly dividend despite a...

Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com